These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 2013216
1. The pharmacokinetics of ceftibuten in humans. Barr WH, Lin CC, Radwanski E, Lim J, Symchowicz S, Affrime M. Diagn Microbiol Infect Dis; 1991; 14(1):93-100. PubMed ID: 2013216 [Abstract] [Full Text] [Related]
2. Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use. Kearns GL, Young RA. Clin Pharmacokinet; 1994 Mar; 26(3):169-89. PubMed ID: 8194281 [Abstract] [Full Text] [Related]
3. Failure of ceftibuten to alter single dose theophylline clearance. Bachmann K, Schwartz J, Jauregui L, Martin M, Nunlee M. J Clin Pharmacol; 1990 May; 30(5):444-8. PubMed ID: 2347955 [Abstract] [Full Text] [Related]
4. Multiple-dose pharmacokinetics of ceftibuten after oral administration to healthy volunteers. Bressolle F, Galtier M, Kinowski JM, Goncalves F, Edno L, Panis R, Gomeni R. J Pharm Sci; 1994 Sep; 83(9):1236-40. PubMed ID: 7830237 [Abstract] [Full Text] [Related]
7. Pharmacokinetics and dose proportionality of ceftibuten in men. Lin C, Lim J, Radwanski E, Marco A, Affrime M. Antimicrob Agents Chemother; 1995 Feb; 39(2):359-61. PubMed ID: 7726498 [Abstract] [Full Text] [Related]
8. Multiple-dose pharmacokinetics of ceftibuten in healthy volunteers. Lin C, Radwanski E, Affrime M, Cayen MN. Antimicrob Agents Chemother; 1995 Feb; 39(2):356-8. PubMed ID: 7726497 [Abstract] [Full Text] [Related]
9. Pharmacology and pharmacokinetics of cefprozil. Barriere SL. Clin Infect Dis; 1992 Jun; 14 Suppl 2():S184-8; discussion S195-6. PubMed ID: 1617036 [Abstract] [Full Text] [Related]
11. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Perucca E, Cloyd J, Critchley D, Fuseau E. Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564 [Abstract] [Full Text] [Related]
12. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers. Nix DE, Symonds WT, Hyatt JM, Wilton JH, Teal MA, Reidenberg P, Affrime MB. Pharmacotherapy; 1997 Jul; 17(1):121-5. PubMed ID: 9017772 [Abstract] [Full Text] [Related]
13. Pharmacokinetics of ceftibuten-cis and its trans metabolite in healthy volunteers and in patients with chronic renal insufficiency. Kelloway JS, Awni WM, Lin CC, Lim J, Affrime MB, Keane WF, Matzke GR, Halstenson CE. Antimicrob Agents Chemother; 1991 Nov; 35(11):2267-74. PubMed ID: 1803999 [Abstract] [Full Text] [Related]
14. Pharmacokinetic drug interaction study: administration of ceftibuten concurrently with the antacid mylanta double- strength liquid or with ranitidine. Radwanski E, Nomeir A, Cutler D, Affrime M, Lin CC. Am J Ther; 1998 Mar; 5(2):67-72. PubMed ID: 10099040 [Abstract] [Full Text] [Related]
15. Comparative bioavailability of ceftibuten in capsule and suspension forms. Lin CC, Affrime M, Radwanski E, Lim J, Colucci R, Cayen MN. Clin Ther; 1996 Mar; 18(6):1139-49. PubMed ID: 9001830 [Abstract] [Full Text] [Related]
16. The pharmacokinetics of the oral cephalosporins--a review. Wise R. J Antimicrob Chemother; 1990 Dec; 26 Suppl E():13-20. PubMed ID: 2292525 [Abstract] [Full Text] [Related]